tiprankstipranks
Trending News
More News >

TherapeuticsMD reports Q2 EPS (24c) vs. ($1.70) last year

Reports Q2 revenue $0.4M vs. $0.3M last year. “The company’s transformation into a royalty-based business is ongoing. As we phase out our historical business operations, we remain focused on reducing costs and conserving cash,” stated Marlan D. Walker, CEO of TherapeuticsMD.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Disclaimer & DisclosureReport an Issue

1